Nussbaum Named Interim Chair of UC's Surgery Department
CINCINNATIThe University of Cincinnati (UC) College of Medicine has appointed Michael Nussbaum, MD, interim chair of the department of surgery following the resignation of Jeffrey Matthews, MD.
Matthews,
who served as Christian R. Holmes professor and surgery chair for five
years, will assume chairmanship of the department of surgery at the
Seeing someone like Jeff leave is always bittersweet, says David Stern, MD, dean of the College of Medicine, but I know Mike will step in where he left off and maintain the momentum for superb patient care and research excellence that the department of surgery has achieved under Jeffs direction.
During his UC tenure, Matthews doubled the department's research fundingelevating UCs department of surgery to 13th in funding from the National Institutes of Health. He also doubled clinical revenue through an expanded clinical trials program, increased surgical weight loss and cosmetic surgery procedures, and multidisciplinary specialized care clinics for pancreatic, liver and vascular disease. The number of UC medical students choosing surgery as their specialty quadrupled as the result of specific initiatives to attract women and other minorities.
Matthews was also instrumental in establishing the Center for Surgical Innovation. This $9.5 million, state-of-the-art research and teaching center brings together military, academic and industry experts to tackle unmet medical needs. Its work focuses specifically on minimally invasive robotic surgery and telesurgery techniques.
Nussbaum,
a 26-year faculty member, is professor and vice chairman of clinical
affairs in UCs surgery department and chief of staff at
This department is about innovation in health care, says Nussbaum, improvements that will make a daily impact on the lives of our patients and teach aspiring surgeons to become better caregivers. Moving forward as a team, well continue that strong vision reinforced under Jeffs leadership and work to propel UCs department of surgery to an even greater future.
Michael Nussbaum, MD, specializes is gastrointestinal and endocrine surgery.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.